4th Quarter - Report
KING & SPALDING LLP for KANEKA PHARMA AMERICA, LLC
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment
Foreign entity interest: Kaneka Corporation, as identified on the LD-1, has an interest in the issues listed above as the owner of Kaneka Pharma America, LLC.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL A ANDREWS | — |
| JEANNINE M BENDER | Staff, Rep. Barton |
| WILLIAM CLARKSON | Leg. Asst. Sen. Collins; Staff Asst. Sen. Coverdell |
| ALEXANDER ("ANDER") M. CRENSHAW | U.S. Representative (FL-04), 2001-2017 |
| DAVID JOSEPH FARBER | — |
| ALLISON F KASSIR | — |
| PREEYA NORONHA PINTO | Deputy GC, Principal Deputy GC, Acting GC, HHS |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.